Michael P. Duffy Sells 21,655 Shares of Lantheus Holdings Inc (LNTH) Stock
Lantheus Holdings Inc (NASDAQ:LNTH) insider Michael P. Duffy sold 21,655 shares of Lantheus stock in a transaction on Wednesday, January 10th. The shares were sold at an average price of $22.40, for a total value of $485,072.00. Following the sale, the insider now directly owns 156,784 shares in the company, valued at approximately $3,511,961.60. The sale was disclosed in a legal filing with the SEC, which is available through this link.
Shares of Lantheus Holdings Inc (NASDAQ LNTH) traded down $0.17 during trading on Friday, reaching $23.48. The company’s stock had a trading volume of 214,257 shares, compared to its average volume of 313,396. The company has a quick ratio of 2.46, a current ratio of 2.96 and a debt-to-equity ratio of -3.41. The company has a market cap of $887.02, a P/E ratio of 28.98, a P/E/G ratio of 1.53 and a beta of 0.94. Lantheus Holdings Inc has a 52-week low of $7.95 and a 52-week high of $24.10.
Lantheus (NASDAQ:LNTH) last announced its earnings results on Thursday, November 2nd. The medical equipment provider reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.20 by $0.04. The firm had revenue of $79.94 million for the quarter, compared to the consensus estimate of $77.18 million. Lantheus had a negative return on equity of 46.45% and a net margin of 9.59%. The firm’s revenue for the quarter was up 9.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.15 EPS. equities research analysts predict that Lantheus Holdings Inc will post 1.05 earnings per share for the current year.
LNTH has been the topic of several recent analyst reports. Zacks Investment Research downgraded Lantheus from a “buy” rating to a “hold” rating in a research note on Wednesday, September 20th. Jefferies Group reaffirmed a “buy” rating and set a $22.00 target price on shares of Lantheus in a research note on Thursday, October 12th. Wells Fargo & Co raised Lantheus from a “market perform” rating to an “outperform” rating in a research note on Thursday, November 2nd. Credit Suisse Group lifted their target price on Lantheus from $19.00 to $23.00 and gave the company a “neutral” rating in a research note on Friday, November 3rd. Finally, ValuEngine downgraded Lantheus from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Lantheus currently has an average rating of “Buy” and a consensus price target of $24.50.
TRADEMARK VIOLATION NOTICE: “Michael P. Duffy Sells 21,655 Shares of Lantheus Holdings Inc (LNTH) Stock” was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The original version of this piece can be accessed at https://www.watchlistnews.com/michael-p-duffy-sells-21655-shares-of-lantheus-holdings-inc-lnth-stock/1805903.html.
Lantheus Company Profile
Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.
Receive News & Ratings for Lantheus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus and related companies with MarketBeat.com's FREE daily email newsletter.